Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2002

Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

(1) , (2) , , (3) , (3) , (4) , (3) , (3) , (5) , (1) , (5) , (2) , , , ,
1
2
3
4
5

Abstract

CD40 ligand (CD40L) is expressed on activated CD4(+) T lymphocytes and at the activated platelet surface. A circulating soluble form of CD40L (sCD40L) is generated by the way of a proteolytic cleavage. We measured sCD40L in the plasma of either healthy subjects; patients with inflammatory disorders and low, normal, or high platelet count (reactive thrombocytosis); or patients with essential thrombocythemia (ET). A tight correlation was found between the platelet count and plasma sCD40L. ET patients had the highest levels of sCD40L. Platelet-associated CD40L was increased in ET and reactive thrombocytosis, conditions associated with increased platelet regeneration. Platelet-associated CD40L was released upon platelet activation. In conclusion, platelets appear as a reservoir of CD40L that may be a major contributor to circulating sCD40L. Platelet-associated CD40L may be a potential marker of platelet regeneration.
Not file

Dates and versions

inserm-02519484 , version 1 (26-03-2020)

Identifiers

Cite

Jean-François Viallard, Anne Solanilla, Bruno Gauthier, Cécile Contin, Julie Déchanet, et al.. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood, 2002, 99 (7), pp.2612-2614. ⟨10.1182/blood.v99.7.2612⟩. ⟨inserm-02519484⟩

Collections

INSERM CNRS
9 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More